Wellnex Life Limited (WNX) fair value: what the stock is really worth
We calculate from audited financials what Wellnex Life Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Jul 11, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch Wellnex Life Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom.
Show more
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Stock analysis
Wellnex Life Limited (WNX) currently trades at £0.0550, while our model-based Fair Value estimate is £0.0317, implying the stock looks roughly 73.5% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 66/100, which puts the evidence level at low.
Scenario range: £0.0317 (bear) to £0.0382 (bull), the price of £0.0550 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 16/100 (below-average quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Wellnex Life Limited reported revenue of A$16.9M in FY2024 versus A$1.2M in FY2021, a compound +142.0%/yr. Reported net income was −A$14.7M in FY2024.
Key figures
Market cap 2.4M GBX · P/S ratio 0.10 · EPS (TTM) £−0.1600 · Net margin −87.0% · Return on equity −151% · Return on assets (EBIT) −46.9% · Operating margin −7.4% · Revenue (TTM) A$24.6M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 27 out of 100 (low confidence).
What moves the price
For context, the median of 10 Consumer Defensive peers we cover trades at −2% fair-value upside, at −42%, WNX screens richer than that median.
Fair Value models
Bear £0.0317Fair Value £0.0317Bull £0.0382
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.30/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−39.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+142.0%
’21
’22
’23
’24
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−777.1% (2021) → −38.1% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 667 stocks
Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score18 · Bottom 25%
Fair Value upside−42% · Bottom 25%
Profitability
Return on assets−14% · Bottom 25%
Net margin (TTM)−40% · Bottom 25%
Operating margin (TTM)−7% · Bottom 25%
Growth and dividend
Revenue growth8% · Above median
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/B0.44× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM)0.13× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 30
FUTURE (revenue growth)40· sector 19
PAST (return on equity)0· sector 29
HEALTH (low debt)0· sector 96
DIVIDEND (yield)0· sector 58
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Wellnex Life Limited Fair Value". https://www.fairvalue-calculator.com/stock/WNX
Frequently asked questions
Is Wellnex Life Limited (WNX) overvalued or undervalued?
As of Jul 11, 2026, our model estimates a fair value of £0.0317 versus a price of £0.0550, about −42% upside (overvalued).
What is the fair value of WNX?
Our model-based fair value for Wellnex Life Limited is £0.0317 (as of Jul 11, 2026), built from audited fundamentals. The current price: £0.0550.
What is the quality score of WNX?
Wellnex Life Limited has a Quality Score of 16/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Wellnex Life Limited (WNX)?
Our model-based price target is the fair value of £0.0317 (as of Jul 11, 2026) from 1 valuation models. Cautious scenario £0.0317, optimistic scenario £0.0382. It is a calculation from audited fundamentals, not an analyst target.
What is the Wellnex Life Limited stock forecast for 2026?
Our models put fair value at £0.0317, about −42% upside versus a price of £0.0550 (overvalued). Cautious scenario £0.0317, optimistic scenario £0.0382. The calculation is refreshed regularly with new filings.
What is the revenue of Wellnex Life Limited (WNX)?
Wellnex Life Limited reported trailing-twelve-month revenue of about A$24.6M (latest available figure, as of Jul 11, 2026).
What is the intrinsic value of Wellnex Life Limited (WNX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Wellnex Life Limited it is £0.0317 per share (as of Jul 11, 2026), against a price of £0.0550. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Wellnex Life Limited stock overvalued or undervalued in 2026?
As of Jul 11, 2026, WNX trades above its calculated fair value: price £0.0550, fair value £0.0317, a gap of about −42% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of WNX?
No. The price is what the market pays today (£0.0550); the fair value is what the company's own numbers justify (£0.0317). For Wellnex Life Limited the two are £0.0233 per share apart. That gap is exactly why we show both numbers side by side.
How much is Wellnex Life Limited worth?
The market values Wellnex Life Limited at about 2.4M GBX (market capitalisation, as of Jul 11, 2026). Per share that is £0.0550; our models calculate a fair value of £0.0317 per share.
What do the bullish and bearish scenarios say about WNX?
Our models span a range for Wellnex Life Limited: cautious scenario £0.0317, base £0.0317, optimistic £0.0382 per share (as of Jul 11, 2026, price £0.0550). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Wellnex Life Limited (WNX)?
Balance-sheet figures for Wellnex Life Limited (as of Jul 11, 2026): return on equity −150.9%. They feed the Quality Score of 16/100, which measures business quality independently of the share price.
Which stocks are comparable to Wellnex Life Limited?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, The Kraft Heinz Company, Foshan Haitian Flavouring and Food Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Wellnex Life Limited stock attractive at the current price?
The data as of Jul 11, 2026: price £0.0550, calculated fair value £0.0317 (−42%), Quality Score 16/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of WNX calculated?
We run Wellnex Life Limited through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of £0.0317, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Wellnex Life Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Wellnex Life Limited (WNX)?
The closing price on Sep 23, 2026 was £0.0550. Our model-based fair value is £0.0317, about −42% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Wellnex Life Limited right now?
The price sits above even our optimistic bull case (£0.0382). The favourable scenario is already priced in. Weak quality (16/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Wellnex Life Limited
How large is the market capitalisation of Wellnex Life Limited (WNX)?
The market capitalisation of Wellnex Life Limited is 2.4M GBX. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Wellnex Life Limited (WNX)?
The price-to-sales ratio of Wellnex Life Limited is 0.10 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Wellnex Life Limited (WNX)?
Earnings per share at Wellnex Life Limited are £−0.1600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Wellnex Life Limited (WNX)?
The net margin of Wellnex Life Limited is −87.0% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Wellnex Life Limited (WNX)?
The return on equity (ROE) of Wellnex Life Limited is −151% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Wellnex Life Limited (WNX)?
On an EBIT basis the return on assets of Wellnex Life Limited is −46.9% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Wellnex Life Limited (WNX)?
The operating margin of Wellnex Life Limited is −7.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Wellnex Life Limited (WNX)?
Revenue at Wellnex Life Limited is growing +8.0% versus a year earlier (3y avg +142%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Wellnex Life Limited (WNX) generate?
The free cash flow of Wellnex Life Limited is −A$6.9M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Wellnex Life Limited (WNX) carry?
The net debt of Wellnex Life Limited is A$9.7M (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Wellnex Life Limited in the live analysis
One click puts Wellnex Life Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
